Scaled Testosterone: A Novel Metric to Calibrate Serum Testosterone and SHBG in Men
Plain-language summary
This study built a better way to read testosterone in men, especially men with obesity, by accounting for SHBG (sex hormone-binding globulin, a protein that binds testosterone and sets how much is free and usable). Pooling data from more than 10,000 men across three Australian studies, the researchers created a measure called Scaled Testosterone that compares testosterone and SHBG directly and sidesteps the unreliable 'free testosterone' math. They found that in obese men a low testosterone reading usually comes with a low SHBG, a pattern they call pseudo-hypogonadism of obesity (a low reading driven by low SHBG rather than a true failure of the testicles). The measure held steady as men lost weight, suggesting the low number was not a real hormone disorder.
Key findings
- Scaled Testosterone (ST) compares standardized testosterone and SHBG levels without relying on free testosterone fractions.
- In obese men, low testosterone is proportionate to low SHBG, suggesting pseudo-hypogonadism rather than true hypogonadism.
- ST remained within standard limits during diet-induced weight loss in obese men.
How to analyze the study yourself
- Study type
- This design is good for developing new metrics and testing them in large populations, but it may not capture individual variability or long-term outcomes.
- Population
- The study included men from three population-based studies in Australia and a clinical trial of men with severe obesity.
- Funding
- Not reported
- Watch for
- This study found that low testosterone in men with obesity is often a quirk of low SHBG, not true deficiency. If you carry extra weight and your testosterone reads low, it may be worth losing weight and re-testing before considering hormone therapy.